Grafting mouse brains: From neurocarcinogenesis to neurodegeneration

EMBO Journal

Volumn 17, Issue 21, 1998, Pages 6107-6114

  Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PRION PROTEIN; PROTEIN TYROSINE KINASE; TUMOR ANTIGEN; VIRUS MIDDLE T ANTIGEN;

B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; BRAIN GRAFT; CANCER IMMUNOTHERAPY; CREUTZFELDT JAKOB DISEASE; GENE TRANSFER; HUMAN; LATENT PERIOD; NERVE DEGENERATION; NERVOUS SYSTEM TUMOR; NEUROECTODERM TUMOR; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; REVIEW;

ANIMALS; AWARDS AND PRIZES; BRAIN NEOPLASMS; GENETIC VECTORS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEURODEGENERATIVE DISEASES; PRION DISEASES; PRIONS; TISSUE TRANSPLANTATION;

EID: 0032476607     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.21.6107     Document Type: Review

References (76)

1. Aguzzi, A. (1993) The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim. Biophys. Acta, 1155, 1-24.
2. Aguzzi, A. (1996) Between cows and monkeys. Nature, 381, 734.
3. Aguzzi, A. and Weissmann, C. (1996) Spongiform encephulopathies: a suspicious signature. Nature, 383, 666-667.
4. Aguzzi, A. and Collinge, J. (1997) Post-exposure prophylaxis after accidental prion inoculation. Lancet, 350, 1519-1520.
5. Aguzzi, A. and Weissmann, C. (1997) Prion research: the next frontiers. Nature, 389, 795-798.
6. Aguzzi, A. and Weissmann, C. (1998) Spongiform encephalopathies. The prion's perplexing persistence. Nature, 392, 763-764.
7. Aguzzi, A., Wagner, E.F., Williams, R.L. and Courtneidge, S.A. (1990) Sympathetic hyperplasia and neuroblustomas in transgenic mice expressing polyoma middle T antigen. New Biol., 2, 533-543.
8. Aguzzi, A., Kleihues, P., Heckl, K. and Wiestler, O.D. (1991) Cell type-specific tumor induction in neural transplants by retro virus-mediated oncogene transfer. Oncogene, 6, 113-118.
9. guzzi, A., Bothe, K., Anhauser, I., Horak, I., Rethwilm, A. and Wagner, E.F. (1992a) Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol., 4, 225-237.
10. Aguzzi, A., Bothe, K., Wagner, E.F., Rethwilm, A. and Horak, I. (1992b) Human foamy virus: an underestimated neuropathogen? Brain Pathol., 2, 61-69.
11. Aguzzi, A., Wagner, E.F., Netzer, K.O., Bothe, K., Anhauser, I. and Rethwilm, A. (1993) Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am. J. Pathol., 142, 1061-1071.
12. Aguzzi, A., Brandner, S., Marino, S. and Steinbach, J.P. (1996) Transgenic and knockout mice in the study of neurodegenerative diseases. J. Mol. Meet., 74, 111-126.
13. Basler, K., Oesch, B., Scott, M., Westaway, D., Walchli, M., Groth, D.F., McKinley, M.P., Prusiner, S.B. and Weissmann, C. (1986) Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428.
14. Bieniasz, P.D., Erlwein, O., Aguzzi, A., Rethwilm, A. and McClure, M.O. (1997) Gene transfer using replication-defective human foamy virus vectors. Virology, 235, 65-72.
15. Blättler, T., Brandner, S., Raeber, A.J., Klein, M.A., Voigtländer, T., Weissmann, C. and Aguzzi, A. (1997) PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature, 389, 69-73.
16. Bosma, M.J. and Carroll, A.M. (1991) The SCID mouse mutant: definition, characterization and potential uses. Annu. Rev. Immunol., 9, 323-350.
17. Bothe, K., Aguzzi, A., Lassmann, H., Rethwilm, A. and Horak, I. (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science, 253, 555-557.
18. Boulter, C.A., Aguzzi, A., Williams, R.L., Wagner, E.F., Evans, M.J. and Beddington, R. (1991) Expression of v-src induces aberrant development and twinning in chimeric mice. Development, 111, 357-366.
19. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C. and Aguzzi, A. (1996a) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature, 379, 339-343.
20. Brandner, S., Raeber, A., Sailer, A., Blaettler, T., Fischer, M., Weissmann, C. and Aguzzi, A. (1996b) Normal host prion protein (PrPC) required for scrapie spread within the central nervous system. Proc. Natl Acad. Sci. USA, 93, 13148-13151.
21. Brandner, S., Isenmann, S., Kuhne, G. and Aguzzi, A. (1998) Identification of the end stage of scrapie using infected neural grafts. Brain Pathol., 8, 19-27.
22. Büeler, H.R., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P., Aguet, M. and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell, 73, 1339-1347.
23. Büeler, H.R., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., DeArmond, S.J., Prusiner, S.B., Aguet, M. and Weissmann, C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 356, 577-582.
24. Cooper, J.A., Gould, K.L., Cartwright, C.A. and Hunter, T. (1986) Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science, 231, 1431-1434.
25. Courtneidge, S.A. and Smith, A.E. (1983) Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature, 303, 435-439.
26. Fischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A. and Weissmann, C. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J., 15, 1255-1264.
27. Fraser, H. (1982) Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature, 295, 149-150.
28. Fung Leung, W.P., Schilham, M.W., Rahemtulla, A., Kundig, T.M., Vollenweider, M., Potter, J., van Ewijk, W. and Mak, T.W. (1991) CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell, 65, 443-449.
29. Giacomini, P., Aguzzi, A., Pestka, S., Fisher, P.B. and Ferrone, S. (1984) Modulation by recombinant DNA leukocyte (α) and fibroblast (β) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J. Immunol., 133, 1649-1655.
30. Giacomini, P., Aguzzi, A., Tecce, R., Fisher, P.B. and Ferrone, S. (1985a) A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon-treated human melanoma cells. Eur. J. Immunol., 15, 946-951.
31. Giacomini, P., Imberti, L., Aguzzi, A., Fisher, P.B., Trinchieri, G. and Ferrone, S. (1985b) Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon. J. Immunol., 135, 2887-2894.
32. Giacomini, P., Aguzzi, A. and Ferrone, S. (1986) Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells. Hybridoma, 5, 277-288.
33. Gray, P.W. et al. (1982) Expression of human immune interferon cDNA in E.coli and monkey cells. Nature, 295, 503-508.
34. Hilberg, F., Aguzzi, A., Howells, N. and Wagner, E.F. (1993) c-jun is essential for normal mouse development and hepatogenesis [published erratum appears in Nature (1993), 366, 368]. Nature, 365, 179-181.
35. Isaacs, A. and Lindenmann, J. (1957) Virus interference, 1. The interferon. Proc. R. Soc. Lond., 147, 258-273.
36. Isenmann, S., Brandner, S., Kuhne, G., Boner, J. and Aguzzi, A. (1996a) Comparative in vivo and pathological analysis of the blood-brain barrier in mouse telencephalic transplants. Neuropathol. Appl. Neurobiol., 22, 118-128.
37. Isenmann, S., Brandner, S., Sure, U. and Aguzzi, A. (1996b) Telencephalic transplants in mice: characterization of growth and differentiation patterns. Neuropathol. Appl. Neurobiol., 21, 108-117.
38. Isenmann, S., Molthagen, M., Brandner, S., Bartsch, U., Kühne, G., Magyar, J.P., Sure, U., Schachner, M. and Aguzzi, A. (1995) The AMOG AMOG/β2 subunit of Na, K-ATPase is not necessary for long term survival of telencephalic grafts. Glia, 15, 377-388.
39. Jonkers, J. and Berns, A. (1996) Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta, 1287, 29-57.
40. Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., Zinkernagel, R.M. and Hengartner, H. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369, 31-37.
41. Kiefer, F., Anhauser, I., Soriano, P., Aguzzi, A., Courtneidge, S.A. and Wagner, E.F. (1994) Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases. Curr. Biol., 4, 100-109.
42. Kitamoto, T., Muramoto, T., Mohri, S., Dohura, K. and Tateishi, J. (1991) Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol., 65, 6292-6295.
43. Kitamura, D., Roes, J., Kuhn, R. and Rajewsky, K. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature, 350, 423-426.
44. Klein, M.A. et al. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature, 390, 687-690.
45. Lampe, J., Marino, S., Rethwilm, A. and Aguzzi, A. (1998) Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus. Neuropathol. Appl. Neurobiol., 24, 36-43.
46. Lasmezas, C.I., Cesbron, J.Y., Deslys, J.P., Demaimay, R., Adjou, K.T., Rioux, R., Lemaire, C., Locht, C. and Dormont, D. (1996) Immune system-dependent and -independent replication of the scrapie agent. J. Virol. 70, 1292-1295.
47. Magyar, J.P., Bartsch, U., Wang, Z.Q., Howells, N., Aguzzi, A., Wagner, E.F. and Schachner, M. (1994) Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the β2 subunit of murine Na, K-ATPase. J. Cell Biol., 127, 835-845.
48. Manson, J.C. Clarke, A.R., McBride, P.A., McConnell, I. and Hope, J. (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration, 3, 331-340.
49. Marino, S., Kretschmer, C., Brandner, S., Cavard, C., Zider, A., Briand, P., Isenmann, S., Wagner, E.F. and Aguzzi, A. (1995) Activation of HIV transcription by human foamy virus in transgenic mice. Lab. Invest., 73, 103-110.
50. Mombaerts, P., Iacomini, J., Johnson, R.S., Herrup, K., Tonegawa, S. and Papaioannou, V.E. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68, 869-877.
51. Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ecsodi, J., Boll, W., Cantell, K. and Weissmann, C. (1980) Synthesis in E.coli of a polypeptide with human leukocyte interferon activity. Nature, 284, 316-320.
52. Natali, P.G., Aguzzi, A., Veglia, F. Imai, K., Burlage, R.S., Giacomini, P. and Ferrone, S. (1983) The impact of monoclonal antibodies on the study of human malignant melanoma. J. Cutan. Pathol., 10, 514-528.
53. Netzer, K.O., Schliephake, A., Maurer, B., Watanabe, R., Aguzzi, A. and Rethwilm, A. (1993) Identification of pol-related gene products of human foamy virus. Virology, 192, 336-338.
54. Nonoyama, S., Smith, F.O., Bernstein, I.D. and Ochs, H.D. (1993) Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol., 150, 3817-3824.
55. Oesch, B. et al. (1985) A cellular gene encodes scrapie PrP 27-30 protein Cell. 40, 735-46.
56. Oesch, B., Groth, D.F., Prusiner, S.B. and Weissmann, C. (1988) Search for a scrapie-specific nucleic acid: a progress report. Ciba. Found. Symp., 135, 209-223.
57. O'Rourke, K.I., Huff, T.P., Leathers, C.W., Robinson, M.M. and Gorham, J.R. (1994) SCID mouse spleen does not support scrapie agent replication. J. Gen. Virol., 75, 1511-1514.
58. Rahemtulla, A. et al. (1991) Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature, 353, 180-184.
59. Rothe, J. et al. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364, 798-802.
60. Sailer, A., Büeler, H., Fischer, M., Aguzzi, A. and Weissmann, C. (1994) No propagation of prions in mice devoid of PrP. Cell, 77, 967-968.
61. Sakaguchi, S. et al. (1995) Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent. J. Virol., 69, 7586-7592.
62. Schmidt, M., Niewiesk, S., Heeney, J., Aguzzi, A. and Rethwilm, A. (1997) Mouse model to study the replication of primate foamy viruses. J. Gen. Virol., 78, 1929-1933.
63. Shinkai, Y. et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D)J rearrangement. Cell, 68, 855-867.
64. Thomas, J.E., Aguzzi, A., Soriano, P., Wagner, E.F. and Brugge, J.S. (1993) Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Oncogene, 8, 2521-2529.
65. Thomas, J.E., Soriano, P. and Brugge, J.S. (1991) Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase. Science, 254, 568-571.
66. Tschopp, R.R., Brandner, S., Marino, S., Bothe, K., Horak, I., Rethwilm, A. and Aguzzi, A. (1996) Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice. Virology, 216, 338-346.
67. Wagner, E.F. (1990) EMBO medal review. On transferring genes into stem cells and mice. EMBO J., 9, 3024-3032.
68. Wagner, E.F. and Aguzzi, A. (1992) Exploring the pathogenic potential of polyoma middle T, c-fos and Human Foamy Virus in transgenic mice. In Theuring, F. and Wagner, E.F. (eds). Transgenic Animals as Model Systems for Human Diseases. Springer, Berlin, Germany, pp. 109-198.
69. Weissenberger, J., Steinbach, J.P., Malin, G., Spada, S., Rulicke, T. and Aguzzi, A. (1997) Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene, 14, 2005-2013.
70. Weissmann, C. (1989) Prions. Sheep disease in human clothing. Nature, 338, 298-299.
71. Weissmann, C. (1991a) Spongiform encephalopathies. The prion's progress. Nature, 349, 569-571.
72. Weissmann, C. (1991b) A 'unified theory' of prion propagation. Nature, 352, 679-683.
73. Weissmann, C. and Aguzzi, A. (1997) Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr. Opin. Neurobiol., 7, 695-700.
74. Will, R.G. et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921-925.
75. Williams, R.L., Risau, W., Zerwes, H.G., Drexler, H., Aguzzi, A. and Wagner, E.F. (1989) Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell. 57, 1053-1063.
76. Zijlstra, M., Bix, M., Simister, N.E., Loring, J.M., Raulet, D.H. and Jaenisch, R. (1990) Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 344, 742-746.